Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000878088-14-000019
Filing Date
2014-08-11
Accepted
2014-08-11 16:20:09
Documents
12
Period of Report
2014-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q prx-20140630x10q.htm 10-Q 2179782
2 EXHIBIT ex101holdings2012equitypla.htm EX-10.1 74757
3 CEO CERT EXHIBIT prx-20140630xex311.htm EX-31.1 13286
4 CFO CERT EXHIBIT prx-20140630xex312.htm EX-31.2 13270
5 CEO CERTIFICATION prx-20140630xex321.htm EX-32.1 5993
6 CFO CERTIFICATION prx-20140630xex322.htm EX-32.2 5587
  Complete submission text file 0000878088-14-000019.txt   16055811

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT prx-20140630.xml EX-101.INS 2959174
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT prx-20140630.xsd EX-101.SCH 85632
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT prx-20140630_cal.xml EX-101.CAL 111140
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT prx-20140630_def.xml EX-101.DEF 517186
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT prx-20140630_lab.xml EX-101.LAB 978039
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT prx-20140630_pre.xml EX-101.PRE 646888
Mailing Address 300 TICE BOULEVARD WOODCLIFF LAKE NJ 07677
Business Address 300 TICE BOULEVARD WOODCLIFF LAKE NJ 07677 201-802-4000
PAR PHARMACEUTICAL COMPANIES, INC. (Filer) CIK: 0000878088 (see all company filings)

EIN.: 223122182 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-10827 | Film No.: 141030798
SIC: 2834 Pharmaceutical Preparations